2 Stocks to Buy Under $10 That Wall Street Loves While penny stocks are risky, they also have the potential to deliver outsized gains. Barchart · Oct 29, 2025
3 Under-the-Radar Biotechs Under $5 That Could Soar 200% 3 biotech stocks under $5 with cancer, obesity, and psychedelic therapies offer speculative investors high-risk, high-reward potential: HOTH, SILO, and ANIX. MarketBeat · Sep 9, 2025
EXCLUSIVE: Hoth Therapeutics' Antisense Therapy Demonstrates Efficacy Against KIT-Driven Cancers Hoth Therapeutics Inc. (NASDAQ:HOTH) on Tuesday announced combined findings from multiple preclinical programs evaluating its precision antisense candidate HT-KIT. Benzinga · Sep 2, 2025
Hoth Therapeutics Plunges Afterhours On Secondary Public Offering Of Common Stock Hoth Therapeutics Inc (NASDAQ:HOTH) says it has commenced an underwritten public offering. Details were not disclosed. The company's proposed offering of the common stock is being offered under a "shelf" registration statement on Form S-3 filed with SEC and declared effective by the SEC on March 11, 2020. A prospectus supplement describing… Benzinga · Apr 11, 2022
Hoth Therapeutics' Novel Cancer Drug Prevented Cell Growth, Induced Cell Death Over 72 hours Hoth Therapeutics Inc (NASDAQ: HOTH) shares are surging after Benzinga · Apr 11, 2022
Why Hoth Therapeutics Shares Are Rising Hoth Therapeutics Inc (NASDAQ: HOTH) shares are trading higher by 125.5% at $1.38 after the company said its mRNA frame-shifting therapeutic proved effective against aggressive cancer cells. Benzinga · Apr 11, 2022